2nd Pharma, Pricing & Marketing Access 2016

Key Topics

• EU and US policy challenges for market access: Stepping ahead
• Preparing your best market access strategy
• Current & future - Challenges & opportunities in pharma pricing, reimbursement & market access
• Opportunity to expose and address the market access challenges facing the industry
• Measurement strategies through to in-depth knowledge regarding payer formulary coverage trends
• Improving patient and market access through the development of targeted value propositions, comprehensive contract assessment
• Payers’ perspective
• How can payers and industry work together to ensure that innovative and valuable treatments make it to the market?
• Creating a robust patient services and reimbursement support program for biosimilar products
• Advocating and collaborating with payers for value in a new era
• How price affects market access and learn on how to set prices for optimal access and returns
• Prioritising Patients! - Adding value through an innovative patient-centered approach
• Evidence Generation - The strategic rigor and creativity applied to evidence generation
• New drugs are failing to gain reimbursement from payers/HTAs at an alarming rate, despite being approved by regulators
• Risk-sharing reimbursement models and value based pricing
• Impact of social media and digital analytics
• How to use the data sources and observational research for effective safety analysis
• Patient engagement and adherence within the environment
• New medicine introduction in developing world & overcoming challenges
• Dwell ahead of regulatory developments & improving your strategies in a cost effective way in EU, US

Who should Attend

Pharmaceutical, biotechnology and regulatory representatives such as:

• Reimbursement
• Pricing
• Commercial Pricing
• Market Access
• Health Economics
• Pricing Strategists
• Regulatory Affairs
• Outcomes Research
• Public Affairs
• Governmental Affairs
• Operations
• Public Policy Directors
• Regulatory bodies
• Governmental bodies